2 APRIL

NEW ZEALAND GAZETTE

First Schedule

Iopronic acid.
Iothalamic acid.
Iotroxic acid.
Ioversol.
Ioxaglic acid.
Ipodate, sodium.
Isoetharine; and its salts; in medicines for inhalation or parenteral use.
Isradipine.
Itraconazole.
Ketanserin.
Ketorolac; and its salts.
L-asparaginase.
Lacidipine.
Lamotrigine.
Leucovorin; and its salts.
Liquorice deglycyrrhizinised.
Lofexidine; and its salts.
Lomefloxacin; and its salts.
Measles vaccine.
Meningococcal vaccine.
Mercaptoethane sulphonate sodium (mesna).
Mesalazine.
Metrizamide.
Metrizoic acid, and its salts.
Milrinone.
Moclobemide.
Molgramostim.
Mono-octanoin.
Mometasone; and its esters.
Moracizine; and its salts.
Mumps vaccine.
Nafarelin; and its salts.
Naproxen; and its salts; except where specified elsewhere in this notice.
Nicardipine.
Nicergoline.
Nilutamide.
Nisoldipine.
Nizatidine.
Octreotide.
Olsalazine sodium.
Ondansetron; and its salts.
Oxandrolone.
Pamidronate disodium.
Paroxetine.
Pentagastrin.
Perindopril.
Permethrin; in medicines containing more than 1% of permethrin.
Phenylephrine; and its salts; in eye preparations containing more than 0.12% of phenylephrine.
Pilocarpine; and its salts; except when sold to a registered optometrist for the purpose of use in his practice as an optometrist.
Pinacidil.
Pipecuronium bromide.

Podophyllotoxin; except when specified elsewhere.
Podophyllum extracts; tinctures of podophyllum; podophyllum; in medicines containing more than 20% of podophyllum.
Pravastatin, and its salts.
Propylidone.
Radiographic contrast media; unless specified elsewhere in this notice.
Quinapril.
Quinine; and its salts; in medicines containing more than 50mg per recommended daily dose.
Ramipril.
Remoxipride.
Ribavirin.
Roxithromycin.
Rubella vaccine.
Salmeterol.
Septomonab.
Sermorelin.
Simvastatin.
Sodium diethocarb.
Sodium ipodate.
Solanaceous alkaloids; and their salts; in medicines containing more than 0.15% of solanaceous alkaloids calculated as hyoscyamine.
Somatropin.
Steroid hormones; either natural or synthetic, which exhibit anabolic activity.
Stramonium; alkaloids of; and their salts; in medicines containing 0.15% or more of alkaloids calculated as hyoscyamine.
Sultamicillin; and its salts.
Sumatriptan; and its salts.
Tazobactam.
T cell receptor antibody.
Temafloxacin.
Terazosin; and its salts.
Terbinafine; except for external use.
Thymoxamine; except when used by an optometrist for use in his practice as an optometrist.
Tolrestat.
Triptorelin.
Tropicamide; except when sold to a registered optometrist for the purpose of use in his practice as an optometrist.
Tropisetron.
Vigabatrin.
Xamoterol.
Zinc; in medicines containing more than 25 mg of elemental zinc per recommended daily dose.
Zuclopenthixol; and its salts and esters.

Second Schedule

Restricted Medicines

Aciclovir; in medicines for external use; except in medicines for ophthalmological use.
Alcohol, absolute; in medicines for internal and external use, except when compounded in a medicine.
Aminacrine; and its salts; in medicines for external use.
Amphotericin; for buccal use.
Aspirin; in enteric-coated and slow-release forms.
Benzocaine; in medicines for animal use.
Benzydamine; and its salts; in medicines for external use.
Betamethasone; and its esters; in medicines for external use containing 0.1% or less of betamethasone.
Bezafibrate.
Buclizine; and its salts; except in medicines containing 25 mg or less per recommended daily dose.
Calcitriol.
Captopril; except in medicines containing 12.5 mg or less per recommended daily dose.
Cetirizine; and its salts; except in medicines containing 10 mg or less per recommended daily dose.